Lumos Diagnostics Pty Ltd (USA)

Description

Develop a rapid point-of-care assay panel that can differentiate among the primary sources of nicotine to enable stronger correlations of nicotine sources with biomarkers of harm

Area of Focus

Research and projects regarding quitting or switching; Verification studies

Approval Date

February 2019

End Date

September 2021